SARMs and Steroids, which is better?

November 24, 2020 By admin 0

SARMs are the newest category of sports pharmaceuticals designed to effectively and safely support the training and competition process. Unlike anabolic steroids, SARMs do not block endogenous testosterone secretion and do not lead to the development of unwanted effects inherent in steroid courses. After completing the course intake of SARMs, the athlete retains all the recruited muscle mass; the rollback phenomenon is absent or is expressed to a minimum degree.

What are SARMs?

SARMs are a heterogeneous category of pharmaceuticals that promote rapid athletic performance. SARMs stimulate lean mass gain, block catabolism, boost peak strength, accelerate subcutaneous fat burning with detailed muscle definition, and increase endurance for training and competition. The positive effects are achieved without the side effects typical of steroid courses.

The unique properties of drugs from the SARMs category are explained by the selectivity of their action. The abbreviation SARMs stands for Selective Androgen Receptor Modulators. Similar to testosterone, selective modulators activate sex hormone receptors in muscle, cartilage, bone, and adipose tissue. By activating receptors in these target organs, the desired effects are achieved.

Receptors for testosterone in other tissues (endocrine system, testicles, glandular tissue of the prostate, hair follicles, sebaceous glands) do not activate selective modulators. This explains the absence of those side effects, without which the course of anabolic steroids rarely does. On the course of SARMs, the synthesis of its own androgens is not suppressed, there is no risk of prostate hypertrophy and atrophy of the gonads. There is no risk of gynecomastia, male pattern hair loss, fluid retention, and hypertension.

SARMs Do Not Depress Testosterone Synthesis:

Selective modulators do not suppress endogenous androgen synthesis, or affect the secretion of sex hormones to a minimum.

All anabolic steroids act not only on muscle androgen receptors, but also on cells of the endocrine system. This leads to negative consequences in the form of inhibition of the production of its own sex hormones and, as a result, atrophy of the gonads.

Selective modulators do not suppress the synthesis of their own hormones and do not provoke testicular atrophy. The absence of a negative effect on the secretion of endogenous hormones is explained by the selectivity of the action. SARMs do not activate nuclear receptors in the sex glands and other parts of the genital arch (pituitary gland, hypothalamus). They are only active in muscle and adipose tissue.

Some representatives of this category ( Ibutamoren ) do not act at all on nuclear receptors for sex hormones, which completely excludes the possibility of suppression of the genital arch. Other SARMs, such as Ligandrol , can moderately suppress testosterone secretion in high doses, so a short PCT is recommended after taking certain SARMs.

SARMs are not converted to estrogens:

SARMs are not affected by the aromatase enzyme. In the athlete’s body, selective modulators are not converted to estrogen.

Many anabolic steroids, including all testosterone esters, are converted into estradiol and its derivatives (estrogens) in the athlete’s body under the action of the aromatase enzyme. The conversion of anabolic steroids into estrogens is the cause of many side effects of the course:

  • Estrogens block the synthesis of endogenous testosterone (estrogen suppression of the genital arc);
  • Estrogens affect the target glandular organs, including the rudimentary mammary glands in the male body. It is estrogens that provoke gynecomastia – a common side effect of the steroid course in the form of breast tightening and enlargement;
  • Estrogens retain fluid, which leads to arterial hypertension, worsens muscle definition and entails a strong rollback after the course (athletes lose more than 60% of the gained weight).

Selective androgen receptor modulators are not converted to estrogens. There are no side effects listed above on a course of SARMs. You do not need to take antiestrogens (aromatase inhibitors) on a SARMs course.

SARMs do not convert to dihydrotestosterone (DHT):

SARMs do not convert to dihydrotestosterone. There is no risk of developing androgenic side effects in the form of hair loss, acne, and prostate hypertrophy on the SARMs course.

The third group of side effects of steroid courses is explained by the fact that an excess of exogenous testosterone or its derivatives is converted into dihydrotestosterone under the action of the enzyme 5-alpha reductase. The latter has a minimal effect on muscle growth, but provokes the side effects listed above, from hair loss to BPH (prostatic hyperplasia).

Selective androgen receptor modulators are not affected by the enzyme 5-alpha reductase. They do not convert to DHT, so there are no androgenic side effects on SARMs.

There is no rollback after the SARMs course:

After a course based on selective androgen receptor modulators, the athlete does not lose the gained muscle mass, or the rollback is minimal.

The absence of a rollback phenomenon after a course of SARMs is explained by the fact that the drugs do not retain water. Weight gain occurs exclusively due to the processes of muscle hypertrophy and hyperplasia, which are based on the synthesis of new proteins of the contractile complex. Usually, after a course of SARMs, the athlete is able to fully maintain the gained muscle mass. The minimum rollback is possible; it is usually caused by a sharp decrease in training intensity after the end of pharmaceutical support.

There is always a rollback after anabolic steroid courses. The most dramatic rollback with a loss of more than 50% of the gained mass is observed after the protocols with testosterone esters, aromatizing steroids and anabolic steroids with progestogenic activity (nandrolone, trenbolone).

How SARMs differ from steroids. Outcomes:

SARMs are modern pharmaceuticals for comprehensive support of the training process. Unlike anabolic steroids, SARMs:

  • Do not inhibit the synthesis of sex hormones;
  • Do not lead to atrophy of the gonads;
  • Do not convert to estrogen;
  • Do not provoke androgenic side effects;
  • Stimulates a high-quality mass gain due to muscle hypertrophy and hyperplasia.

You do not need to take aromatase inhibitors (antiestrogens) or other drugs that stimulate endogenous testosterone production on a SARM course. Post-cycle therapy is not required or is carried out to a minimum. There is no rollback after SARMs are received. Athletes manage to maintain all the muscle mass gained.

Selective androgen receptor modulators are widely used by professional and amateur athletes. Another advantage of SARMs is the convenient form of release (tablets, capsules), which eliminates the need for painful injections of oil solutions.